Viking Therapeutics, Inc. ("Viking") (NASDAQ: VKTX), a clinical-stage biopharmaceutical company focused on the development of novel therapies for metabolic and endocrine disorders, today announced ...

Eli Lilly (NYSE: LLY) sells a broad range of pharmaceuticals treating various diseases, but one portfolio in particular has ...

More Viking Age silver has been discovered per square kilometer on the Isle of Man than in England, Ireland, Scotland, and ...

Fintel reports that on November 12, 2024, Morgan Stanley upgraded their outlook for Viking Holdings (NYSE:VIK) from ...

Sam Darnold has experienced a career revival his his first season with the Minnesota Vikings.

If the Vikings get to the post-season and do well, Darnold as a free agent could cost nearly $40 million a year on a new ...

On Tuesday, Viking Therapeutics Inc (VKTX) stock saw a decline, ending the day at $60.6 which represents a decrease of $-2.37 or -3.76% from the prior close of $62.97. The stock opened at $62.46 and ...

Use precise geolocation data and actively scan device characteristics for identification. This is done to store and access ...

In recent trading, Viking Therapeutics Inc (VKTX) stock price has shown some volatility, fluctuating -6.04% over the last five trades and 9.66% over the past 30 trades. This represents a notable shift ...

Love travelling but despise long flight times? Check out the world's shortest commercial flight, operate by Loganair, that ...

I FEEL about six years old, hands and knees covered in thick mud, as I emerge from a tunnel only big enough to crawl through, first used by Christian settlers more than 1,200 years ago to escape ...